OMAHA, Neb., Nov. 5, 2025 /PRNewswire/ -- Tekton Research, a leading multispecialty clinical trial site organization conducting Phase 1-4 trials,…
NV-387 Could be the Answer to the MPox Clade I Rising in the USA, Says Dr. Diwan SHELTON, CONNECTICUT /…
The successful vaccine trials for honeybees, together with recent breakthrough results from clinical trials for disease prevention in shrimp, further…
WAKEFIELD, Mass., Nov. 4, 2025 /PRNewswire/ -- Odyssey, a leading provider of integrated defense capabilities and technologies, announced today it…
Investor event in New York City to provide update on pivotal Phase 3 study of IMNN-001; offering in-person or virtual…
Demonstrated feasibility of effective DNA delivery with Company's xPhore™ nanoparticle technologyDNA delivery technology to be offered as GenePhore™ to biotech…
SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader…
CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has…
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and…
Dr. Jay Greenstein, CEO of Embody Health, joins the Disruption/Interruption podcast to discuss how fusing AI with behavioral science and…